Stockscreener 앱 받기
25.82
1.56%
-0.4109
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Zai Lab Grants Share Units to Employees - Marketscreener.com
Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics - MSN
Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares - BioSpace
ZLABZai Lab Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan
Zai Lab Raises $230M in Oversubscribed Public Offering of American Depositary Shares | ZLAB Stock News - StockTitan
FY2024 EPS Estimates for Zai Lab Increased by Analyst - Defense World
Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume – Here’s What Happened - Defense World
Digital Brands Group Inc (DBGI): Is It Worth A Small Bite At $0.10? - Stocks Register
Thermo Fisher Scientific Inc’s (TMO) Stock Is Harder To Predict Than You Think - Stocks Register
Selling Your MicroAlgo Inc (NASDAQ: MLGO) Stock? Here’s What You Need To Know - Stocks Register
Danaher Corp (DHR): An Important Analyst Insights - Stocks Register
Centerpoint Energy Inc (NYSE: CNP): Blank Check On Growth? - Stocks Register
Do Unitedhealth Group Inc (NYSE: UNH) Provide Stability And Growth? - Stocks Register
Major Improvements In VF Corp (VFC) Stock Need To Be Considered - Stocks Register
A Stock Analysis Of Fortive Corp’s (FTV) - Stocks Register
Dollar Tree Inc’s (DLTR) Stock Is Harder To Predict Than You Think - Stocks Register
BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register
Leerink Partnrs Increases Earnings Estimates for Zai Lab - Defense World
Zai Lab Announces $200M Public Offering at $25.50 per ADS | ZLAB Stock News - StockTitan
Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire
Zai Lab Launches $200M ADS Offering with Goldman Sachs, Jefferies as Lead Managers | ZLAB Stock News - StockTitan
Zai Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Zai Lab Ltd (ZLAB) Reports Q3 2024 Earnings: EPS Loss of $0.04, Revenue at $101.8 Million, Slightly Misses Estimates - GuruFocus.com
abrdn Life Sciences Investors declares $0.50 dividend - MSN
Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for - GlobeNewswire
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Business Wire
Zai Lab (ZLAB) Scheduled to Post Quarterly Earnings on Tuesday - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat
JP Morgan analysts reiterates an Overweight rating for Roku Inc (ROKU) - Knox Daily
Is Patterson Companies Inc (NASDAQ: PDCO) A Suitable Stock For New Investors Today? - Stocks Register
Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China - Business Wire
Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.7% – Here’s What Happened - Defense World
Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last? - MSN
Biopharma operator Zai Lab surges to 16-month high on lung cancer drug trial results - Mugglehead
Trial highlights potential next-gen biologic for lung cancer - Marketscreener.com
Zai Lab (NASDAQ:ZLAB) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat
Zai Lab (NASDAQ:ZLAB) Shares Down 3.7%What's Next? - MarketBeat
Hennion & Walsh Asset Management Inc. Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Zai Lab stock soars to 52-week high, touches $32.5 - Investing.com India
Citi raises Zai Lab target on promising trial results - Investing.com
This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test - Investor's Business Daily
Zai Lab (NASDAQ:ZLAB) Hits New 12-Month HighHere's What Happened - MarketBeat
ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer - BioSpace
Zai Lab Announces Participation in November and December Investor Conferences - BioSpace
JPMorgan Chase & Co. Raises Zai Lab (NASDAQ:ZLAB) Price Target to $44.00 - MarketBeat
Zai Lab (NASDAQ:ZLAB) Shares Up 6.5% – Still a Buy? - Defense World
Zai Lab (NASDAQ:ZLAB) Stock Price Up 6.5%Here's What Happened - MarketBeat
Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 - Business Wire
Zai Lab (NASDAQ:ZLAB) Shares Gap UpShould You Buy? - MarketBeat
Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024 - BioSpace
Dimensional Fund Advisors LP Acquires New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
An Analysis of Zai Lab Limited ADR (ZLAB)’s Potential Price Growth - Knox Daily
Recent Insider Activity Could Benefit Booz Allen Hamilton Holding Corp (BAH) - Knox Daily
Examining the Potential Price Growth of Phillips 66 (PSX) - Knox Daily
Verona Pharma Plc ADR [VRNA] Insider Activity: An Update for Investors - Knox Daily
Analyzing First Solar Inc (FSLR) After Recent Trading Activity - Knox Daily
Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily
Ratios in Focus: Analyzing Zai Lab Limited ADR (ZLAB)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Zai Lab Limited ADR (ZLAB)’s stock chart: A technical perspective - US Post News
Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.2%What's Next? - MarketBeat
1.80%
0.42%
자본화:
|
볼륨(24시간):